Published online before print
October 24, 2007, 10.1183/09031936.00039707
Eur Respir J 2008; 31:320-325
Copyright ©ERS Journals Ltd 2008
Suboptimal asthma control: prevalence, detection and consequences in general practice
K. R. Chapman1,
L. P. Boulet2,
R. M. Rea3 and
E. Franssen3
1 University of Toronto, Toronto, 2 Laval University, Quebec City, Quebec, and 3 GlaxoSmithKline Canada Inc., Mississauga, Ontario, Canada.
CORRESPONDENCE: K. R. Chapman, Asthma and Airway Centre, University Health Network, Toronto Western Hospital, Room 7E-451, 399 Bathurst Street, Toronto, Ontario, M5T 2S8, Canada. Fax: 1 4166033456. E-mail: kchapman{at}ca.inter.net
Keywords: Guideline dissemination, healthcare utilisation
Received: August 3, 2007
Accepted October 11, 2007
Telephone surveys describing suboptimal asthma control may be biased by low response rates.
In order to obtain an unbiased assessment of asthma control and assess its impact in primary care, primary care physicians used a 1-page control questionnaire in 50 consecutive asthma patients.
Of the 10,428 patients assessed by 354 physicians, 59% were uncontrolled, 19% well-controlled and 23% totally controlled. Physicians overestimated control, regarding only 42% of patients as uncontrolled. Physicians were more likely to report plans to alter the regimens of uncontrolled patients than controlled patients (1.29 versus 0.20 medication changes per patient) doing so in a fashion consistent with guideline recommendations. Of the uncontrolled patients, 59% required one or more urgent care or specialist visits versus 26 and 15% of well-controlled or totally controlled patients, respectively. Patients were more likely to report short-term symptom control when they had not required urgent or specialist care (odds ratio 5.68; 95% confidence interval 4.91–6.58).
The majority of asthma patients treated in general practice are uncontrolled. Lack of control can be recognised by physicians who are likely to consider appropriate changes to therapy. A lack of short-term symptom control of asthma is associated with excess healthcare utilisation.
This article has been cited by other articles:

|
 |

|
 |
 
P. Demoly, P. Paggiaro, V. Plaza, S. C. Bolge, H. Kannan, B. Sohier, and L. Adamek
Prevalence of asthma control among adults in France, Germany, Italy, Spain and the UK
Eur. Respir. Rev.,
June 1, 2009;
18(112):
105 - 112.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L-P. Boulet
Influence of comorbid conditions on asthma
Eur. Respir. J.,
April 1, 2009;
33(4):
897 - 906.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. D. Lougheed, N. Garvey, K. R. Chapman, L. Cicutto, R. Dales, A. G. Day, W. M. Hopman, M. Lam, M. R. Sears, K. Szpiro, et al.
Variations and Gaps in Management of Acute Asthma in Ontario Emergency Departments
Chest,
March 1, 2009;
135(3):
724 - 736.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. B. Stanbrook MD PhD and A. Kaplan MD
The error of not measuring asthma
Can. Med. Assoc. J.,
November 18, 2008;
179(11):
1099 - 1100.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. B. Stanbrook MD PhD and A. Kaplan MD
Ne pas evaluer l'asthme : une erreur
Can. Med. Assoc. J.,
November 18, 2008;
179(11):
1101 - 1102.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. Lindmark
Review: Differences in the pharmacodynamics of budesonide/formoterol and salmeterol/fluticasone reflect differences in their therapeutic usefulness in asthma
Therapeutic Advances in Respiratory Disease,
October 1, 2008;
2(5):
279 - 299.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
K. R. Chapman MD MSc
Asthma in Canada: missing the treatment targets
Can. Med. Assoc. J.,
April 8, 2008;
178(8):
1027 - 1028.
[Full Text]
[PDF]
|
 |
|
Copyright © 2008 by the European Respiratory Society.
|